How many drugs treat Urinary bladder stone?

Drug Landscape tracks 1 marketed treatments for Urinary bladder stone (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/urinary-bladder-stone.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Urinary bladder stone — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Urinary bladder stone (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Urinary bladder stone, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Renacidin	GLUCONOLACTONE	United Guardian	Calculi Dissolution Agent [EPC]	Glucosylceramidase		1990-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

United Guardian · 1 drug in Urinary bladder stone

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Urinary bladder stone:

Cite this brief

Drug Landscape (2026). Urinary bladder stone — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/urinary-bladder-stone. Accessed 2026-06-10.

Urinary bladder stone full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing